Evidence map›Paper›PMID 36145164›Full record

ArticleNutrients2022

Diet and

Cristina Hidalgo-Moyano, Oriol Alberto Rangel-Zuñiga, Francisco Gomez-Delgado, Juan F Alcala-Diaz, Fernando Rodriguez-Cantalejo, Elena M Yubero-Serrano, Jose D Torres-Peña, Antonio P Arenas-de Larriva, Antonio Camargo, Pablo Perez-Martinez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Cristina Hidalgo-MoyanoLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.
Oriol Alberto Rangel-ZuñigaLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.ORCID 0000-0003-3495-5705
Francisco Gomez-DelgadoInternal Medicine Unit, Jaen University Hospital, 23071 Jaen, Spain.
Juan F Alcala-DiazLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.ORCID 0000-0002-4572-3611
Fernando Rodriguez-CantalejoBiochemical Laboratory, Reina Sofia University Hospital, 14004 Córdoba, Spain.
Elena M Yubero-SerranoLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.ORCID 0000-0002-2733-5359
Jose D Torres-PeñaLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.
Antonio P Arenas-de LarrivaLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.ORCID 0000-0001-8897-5176
Antonio CamargoLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.ORCID 0000-0002-0415-4184
Pablo Perez-MartinezLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.ORCID 0000-0002-3264-2767
Jose Lopez-MirandaLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.ORCID 0000-0002-8844-0718
Javier Delgado-ListaLipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.ORCID 0000-0002-2982-2716
Instituto de Salud Carlos III · ESHospital Universitario Reina Sofía · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ES

Funding

Consejería de Innovación, Ciencia y Empresa, Proyectos de Investigación de Excelencia, Junta de Andalucía CVI-7450 to J.L-MFondo Europeo de Desarrollo Regional (FEDER) JPI HDHL-NutriCog (PCIN-2016-084 to J.L-M)Fundación Patrimonio Comunal Olivarero, Junta de Andalucía (Consejería de Salud, Consejería de Agricultura y Pesca, Consejería de Innovación, Ciencia y Empresa), Diputaciones de Jaén y Cór-doba, Centro de Excelencia en Investigación sobre Aceite de Oliva NCT00924937Instituto de Salud Carlos III CP19/00142 to O.A.R.Z and CP14/00114 to A.C.Instituto de Salud Carlos III, acción estratégica en salud 2013 FIS-PI13/00185 to J.L-M.Ministerio de Economía y Competitividad AGL2012/39615, PIE14/00005, and PIE 14/00031 to J.L-M; AGL2015-67896-P to J.L-M and AC
6 · The paper itself

Abstract

We investigated whether long-term consumption of two healthy diets (low-fat (LF) or Mediterranean (Med)) interacts with SIRT1 genotypes to modulate aging-related processes such as leucocyte telomere length (LTL), oxidative stress (OxS) and inflammation in patients with coronary heart disease (CHD). LTL, inflammation, OxS markers (at baseline and after 4 years of follow-up) and SIRT1-Single Nucleotide Polymorphisms (SNPs) (rs7069102 and rs1885472) were determined in patients from the CORDIOPREV study. We analyzed the genotype-marker interactions and the effect of diet on these interactions. Regardless of the diet, we observed LTL maintenance in GG-carriers for the rs7069102, in contrast to carriers of the minor C allele, where it decreased after follow-up (p = 0.001). The GG-carriers showed an increase in reduced/oxidized glutathione (GSH/GSSG) ratio (p = 0.003), lower lipid peroxidation products (LPO) levels (p < 0.001) and a greater decrease in tumor necrosis factor-alpha (TNF-α) levels (p < 0.001) after follow-up. After the LF diet intervention, the GG-carriers showed stabilization in LTL which was significant compared to the C allele subjects (p = 0.037), although the protective effects found for inflammation and OxS markers remained significant after follow-up with the two diets. Patients who are homozygous for the SIRT1-SNP rs7069102 (the most common genotype) may benefit from healthy diets, as suggested by improvements in OxS and inflammation in patients with CHD, which may indicate the slowing-down of the aging process and its related diseases.

Indexed as

Coronary DiseaseDiet, MediterraneanAgingGenotypeGlutathione DisulfideHumansInflammationPolymorphism, Single NucleotideSirtuin 1Tumor Necrosis Factor-alphaGlutathione DisulfideSIRT1 protein, humanSirtuin 1Tumor Necrosis Factor-alphaaging-related processescoronary heart diseasegenetic variantshealthy dietsrole of sirtuins

Identifiers

PMID36145164
PMCPMC9504765
OpenAlexW4295926190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.